Back to Clinical Trials Overview

Your search for "Lung" returned 12 results:


Transient Tachypnea of the Newborn: Prospective Evaluation of Fluid Management
Principal Investigator(s): Holzman, ian

Determinants fo Undertreatment Amoung Patients with Chronic Obstructive Pulmonary Disease
Principal Investigator(s): Wisnivesky, Juan P

IBV Valve System for Severe Emphysema
Principal Investigator(s): Harkin, Timothy

Pulmonary Diseases from Secondhand Smoke
Principal Investigator(s): Claudia I. Henschke

A Phase II Randomized Double-Blind Placebo-Controlled Study to Assess the Efficacy and Safety of Lebrikizumab in Patients with Idiopathic Pulmonary Fibrosis
Principal Investigator(s): Maria Padilla

A Phase 2 Open-label Dose-Escalation Study to Evaluate the Safety Tolerability and Efficacy of FG-3019 in Subjects with Idiopathic Pulmonary Fibrosis [Protocol Number FGCL-3019-049]
Principal Investigator(s): Maria Padilla

Center for Chinese Herbal Therapy for Asthma/PROJECT II
Principal Investigator(s): Sampson, Hugh

A Phase 2 Randomized Double-Blind Placebo-Controlled Multi-Center Study to Assess the Efficacy and Safety of GS-6624 in Subjects with Idiopathic Pulmonary Fibrosis (RAINIER)
Principal Investigator(s): Maria Padilla

WTC CHEST (Pulmonary Abnormalities, Diastolic Dysfunction, and World Trade Center Exposure: Implications for Diagnosis and Treatment)
Principal Investigator(s): Mary Ann McLaughlin, MD MPH

A Multi-Centre Open-Label Study of Mepolizumab in a Subset of Subjects with a History of Life Threatening/Seriously Debilitating Asthma Who Participated in the MEA115661 Trial
Principal Investigator(s): Gwen Skloot

Center for Chinese Herbal Therapy for Asthma
Principal Investigator(s): Li, Xiu-Min MD

American Legacy Smoking Cessation Study
Principal Investigator(s): Claudia I. Henschke